PL2125714T3 - Chlorowodorek 5-[3-(3-hydroksyfenoksy)azetydyn-1-ylo]-5-metylo-2,2-difenyloheksanamidu - Google Patents

Chlorowodorek 5-[3-(3-hydroksyfenoksy)azetydyn-1-ylo]-5-metylo-2,2-difenyloheksanamidu

Info

Publication number
PL2125714T3
PL2125714T3 PL08719316T PL08719316T PL2125714T3 PL 2125714 T3 PL2125714 T3 PL 2125714T3 PL 08719316 T PL08719316 T PL 08719316T PL 08719316 T PL08719316 T PL 08719316T PL 2125714 T3 PL2125714 T3 PL 2125714T3
Authority
PL
Poland
Prior art keywords
diphenylhexanamide
hydroxyphenoxy
azetidin
methyl
hydrochloride salt
Prior art date
Application number
PL08719316T
Other languages
English (en)
Inventor
Paul Alan Glossop
Kim James
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39591485&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2125714(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of PL2125714T3 publication Critical patent/PL2125714T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL08719316T 2007-03-16 2008-03-06 Chlorowodorek 5-[3-(3-hydroksyfenoksy)azetydyn-1-ylo]-5-metylo-2,2-difenyloheksanamidu PL2125714T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89516307P 2007-03-16 2007-03-16
EP08719316A EP2125714B1 (en) 2007-03-16 2008-03-06 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide
PCT/IB2008/000622 WO2008135819A1 (en) 2007-03-16 2008-03-06 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide

Publications (1)

Publication Number Publication Date
PL2125714T3 true PL2125714T3 (pl) 2011-10-31

Family

ID=39591485

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08719316T PL2125714T3 (pl) 2007-03-16 2008-03-06 Chlorowodorek 5-[3-(3-hydroksyfenoksy)azetydyn-1-ylo]-5-metylo-2,2-difenyloheksanamidu

Country Status (24)

Country Link
US (1) US8263583B2 (pl)
EP (1) EP2125714B1 (pl)
JP (1) JP4277051B2 (pl)
KR (1) KR101120227B1 (pl)
CN (2) CN101641327A (pl)
AR (1) AR065714A1 (pl)
AT (1) ATE512132T1 (pl)
AU (1) AU2008247095B2 (pl)
BR (1) BRPI0808413A2 (pl)
CA (1) CA2678683C (pl)
CY (1) CY1111701T1 (pl)
DK (1) DK2125714T3 (pl)
ES (1) ES2364727T3 (pl)
HK (1) HK1189591A1 (pl)
IL (1) IL200403A (pl)
MX (1) MX2009009952A (pl)
NZ (1) NZ579056A (pl)
PL (1) PL2125714T3 (pl)
PT (1) PT2125714E (pl)
RU (1) RU2422439C2 (pl)
SI (1) SI2125714T1 (pl)
TW (1) TWI348907B (pl)
WO (1) WO2008135819A1 (pl)
ZA (1) ZA200906462B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102712674A (zh) 2009-11-23 2012-10-03 帕拉丁科技公司 黑皮质素-1受体-特异性的线性肽
EA021897B1 (ru) 2009-11-23 2015-09-30 Палатин Текнолоджиз, Инк. Циклические пептиды, специфичные к рецептору меланокортина-1
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
EP3596046A1 (en) 2017-03-15 2020-01-22 Mylan Laboratories Ltd. Novel polymorphs of (5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide hydrochloride
CN114732910A (zh) 2017-10-05 2022-07-12 弗尔康医疗公司 P38激酶抑制剂降低dux4和下游基因表达以用于治疗fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2020261160A1 (en) * 2019-06-25 2020-12-30 Mylan Laboratories Limited Methods and intermediates for preparing hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide
WO2021260441A1 (en) * 2020-06-26 2021-12-30 Mylan Pharma Uk Limited Formulations including 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide
CN113577059B (zh) * 2021-08-02 2022-05-20 山东大学齐鲁医院(青岛) 一种用于小儿哮喘的活性药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69720518T2 (de) * 1996-12-02 2004-02-26 Kyorin Pharmaceutical Co., Ltd. Neue derivate von n-substituierten pyrrolidin derivaten und deren herstellungsverfahren
JPH11100366A (ja) 1997-09-29 1999-04-13 Kyorin Pharmaceut Co Ltd 新規ｎ−置換環状アミン誘導体及びその製造法
CN101268046B (zh) * 2005-09-21 2012-07-25 辉瑞有限公司 作为毒蕈碱性受体拮抗剂的碳酰胺衍生物
US20100160279A1 (en) * 2006-09-22 2010-06-24 Pfizer Inc Azetidine Derivatives as Muscarinic Receptor Antagonists

Also Published As

Publication number Publication date
AU2008247095A1 (en) 2008-11-13
RU2422439C2 (ru) 2011-06-27
KR101120227B1 (ko) 2012-03-20
BRPI0808413A2 (pt) 2014-07-15
KR20090110944A (ko) 2009-10-23
US8263583B2 (en) 2012-09-11
MX2009009952A (es) 2009-10-08
AR065714A1 (es) 2009-06-24
IL200403A0 (en) 2010-04-29
WO2008135819A1 (en) 2008-11-13
EP2125714B1 (en) 2011-06-08
ES2364727T3 (es) 2011-09-13
PT2125714E (pt) 2011-07-14
TWI348907B (en) 2011-09-21
JP2009001543A (ja) 2009-01-08
TW200904408A (en) 2009-02-01
RU2009134512A (ru) 2011-03-20
IL200403A (en) 2014-08-31
CN103351367B (zh) 2015-06-10
CN101641327A (zh) 2010-02-03
EP2125714A1 (en) 2009-12-02
CA2678683A1 (en) 2008-11-13
ZA200906462B (en) 2010-06-30
JP4277051B2 (ja) 2009-06-10
CY1111701T1 (el) 2015-10-07
AU2008247095B2 (en) 2012-12-13
NZ579056A (en) 2011-07-29
CA2678683C (en) 2012-05-15
WO2008135819A8 (en) 2009-08-27
CN103351367A (zh) 2013-10-16
ATE512132T1 (de) 2011-06-15
US20100113409A1 (en) 2010-05-06
HK1189591A1 (en) 2014-06-13
DK2125714T3 (da) 2011-07-25
SI2125714T1 (sl) 2011-10-28

Similar Documents

Publication Publication Date Title
IL200403A0 (en) Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide
ZA201001901B (en) 5-substituted 2-(alkoxymethyl)furans
IL212186A0 (en) Fungicidal heterocyclic compounds
ZA201103887B (en) Isoxazole derivatives for use as fungicides
IL224109A (en) Isoxazole derivatives for use as fungicides
ZA200806350B (en) Stable, concentrated herbicidal compositions
AP2010005364A0 (en) Novel heterocyclic compounds.
PL2102205T3 (pl) Pochodne pirydopirazyny użyteczne jako związki chwastobójcze
EP2196459A4 (en) 5-GROUND HETEROCYCLIC COMPOUND
IL207854A0 (en) Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol
ZA201008657B (en) 4,5-dihydro-oxazol-2-yl derivatives
ZA200809557B (en) 2-(pyridin-2-yl)-pyrimidines for use as fungicides
EP2155712A4 (en) 3- (imidazolyl) -PYRAZOLOÝ3,4-B¨PYRIDINES
IL229712A (en) The aryl sulfonamide compounds are converted into two positions 2 and 5
IL215727A0 (en) 2,5-disubstituted arylsulfonamide ccr3 antagonists
IL214110A0 (en) 2,3-diaryl-or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
IL205289A0 (en) Amino 1, 2, 4 - triazole derivatives as modulators of mglur5
HK1178887A1 (en) 2,5-substituted oxazolopyrimidine derivatives as edg-1 agonists edg-1 25-
ZA200809554B (en) 3-(pyridin-2-yl)-[1,2,4]-triazines for use as fungicides
HK1161684A1 (en) 5,6-dihydro-1h-pyridin-2-one compounds 56- -1h--2-
EP2189445A4 (en) FIVE-GLASS HETEROCYCLIC CONNECTION
IL213328A0 (en) Regeneration of 2,2'-cyclopropylidene-bis (oxazolines)
AU2007900027A0 (en) Heterocyclic compounds
AU2008903041A0 (en) Feedback loop biosensor